Per Pfeiffer

21.3k total citations · 2 hit papers
302 papers, 6.3k citations indexed

About

Per Pfeiffer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Per Pfeiffer has authored 302 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 237 papers in Oncology, 97 papers in Pulmonary and Respiratory Medicine and 87 papers in Surgery. Recurrent topics in Per Pfeiffer's work include Colorectal Cancer Treatments and Studies (121 papers), Gastric Cancer Management and Outcomes (63 papers) and Cancer Treatment and Pharmacology (59 papers). Per Pfeiffer is often cited by papers focused on Colorectal Cancer Treatments and Studies (121 papers), Gastric Cancer Management and Outcomes (63 papers) and Cancer Treatment and Pharmacology (59 papers). Per Pfeiffer collaborates with scholars based in Denmark, Sweden and Norway. Per Pfeiffer's co-authors include Camilla Qvortrup, Bengt Glimelius, Michael Bau Mortensen, Halfdan Sørbye, Benny Vittrup Jensen, Carsten Rose, Jon Kroll Bjerregaard, Sönke Detlefsen, Martin Graversen and Mette Yilmaz and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Per Pfeiffer

287 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus

2018 362 citations Per Pfeiffer et al. profile →
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

2023 190 citations Thierry Conroy, Per Pfeiffer et al. Annals of Oncology profile →

Peers

Countries citing papers authored by Per Pfeiffer

Since Specialization

Citations

This map shows the geographic impact of Per Pfeiffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Pfeiffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Pfeiffer more than expected).

Fields of papers citing papers by Per Pfeiffer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Pfeiffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Pfeiffer. The network helps show where Per Pfeiffer may publish in the future.

Co-authorship network of co-authors of Per Pfeiffer

This figure shows the co-authorship network connecting the top 25 collaborators of Per Pfeiffer. A scholar is included among the top collaborators of Per Pfeiffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per Pfeiffer. Per Pfeiffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The prognostic role of circulating CA19–9 and CEA in patients with colorectal cancer 2025 ·Cancer Treatment and Research Communications ·(unknown), (unknown), Jakob Vasehus Schou, (unknown), (unknown), Jakob Lykke, Dorte Nielsen, Per Pfeiffer, Camilla Qvortrup, Mette Yilmaz, Ole Larsen, Stig E. Bojesen, Benny Vittrup Jensen, Julia S. Johansen	2
2	Prediction of overall survival in patients with locally advanced pancreatic cancer using longitudinal diffusion-weighted MRI 2024 ·Frontiers in Oncology ·(unknown), Carsten Brink, Tine Schytte, (unknown), (unknown), Uffe Bernchou, A. Bertelsen, Per Pfeiffer, Faisal Mahmood	1
3	Effect of comprehensive geriatric assessment on hospitalizations in older adults with frailty initiating curatively intended oncologic treatment: The PROGNOSIS-RCT study 2024 ·Journal of Geriatric Oncology ·(unknown), (unknown), Marianne Ewertz, Henrik J. Ditzel, Trine Lembrecht Jørgensen, Per Pfeiffer, Cecilia Margareta Lund, Jesper Ryg	1
4	Adaptive MRI-guided stereotactic body radiation therapy for locally advanced pancreatic cancer – A phase II study 2024 ·Radiotherapy and Oncology ·(unknown), (unknown), Tine Schytte, Christian Rønn Hansen, A. Bertelsen, Faisal Mahmood, Michael Bau Mortensen, Sönke Detlefsen, Britta Weber, Uffe Bernchou, Per Pfeiffer	6
5	Treatment Options in Late-Line Colorectal Cancer: Lessons Learned from Recent Randomized Studies 2023 ·Cancers ·Line Schmidt Tarpgaard, Stine Brændegaard Winther, Per Pfeiffer	3
6	Evaluating the efficacy and safety of neoadjuvant pembrolizumab in patients with stage I–III MMR-deficient colon cancer: a national, multicentre, prospective, single-arm, phase II study protocol 2023 ·BMJ Open ·(unknown), Ismail Gögenür, Line Schmidt Tarpgaard, Per Pfeiffer, Camilla Qvortrup	1
7	Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up breakdown → 2023 ·Annals of Oncology ·Thierry Conroy, Per Pfeiffer, Valérie Vilgrain, Ángela Lamarca, Thomas Seufferlein, Eileen M. O’Reilly, Thilo Hackert, Talia Golan, Gerald W. Prager, Karin Haustermans, Arndt Vogel, Michel Ducreux	190
8	Fluoropyrimidine-induced hand-foot syndrome and cardiotoxicity: recommendations for the use of the oral fluoropyrimidine S-1 in metastatic colorectal cancer 2023 ·ESMO Open ·Cornelis J.A. Punt, Volker Heinemann, Tim Maughan, Chiara Cremolini, Eric Van Cutsem, Ray McDermott, (unknown), Thierry André, Pia Österlund, Arco J. Teske, Per Pfeiffer	4
9	P-241 Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil plus bevazicumab: Final analysis from a Danish randomised study 2023 ·Annals of Oncology ·Per Pfeiffer, Stine Brændegaard Winther, Sören Möller, Laurids Østergaard Poulsen, (unknown), Camilla Qvortrup	0
10	A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01) 2023 ·BMC Cancer ·(unknown), Stine Brændegaard Winther, Inna M. Chen, Britta Weber, Lise Ventzel, Gábor Liposits, Julia S. Johansen, Sönke Detlefsen, (unknown), (unknown), (unknown), Per Pfeiffer, Morten Ladekarl	1
11	What is long-term survival in patients with peritoneal metastasis from gastric, pancreatic, or colorectal cancer? A study of patients treated with systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC) 2023 ·SHILAP Revista de lepidopterología ·(unknown), Claus Wilki Fristrup, Alan Patrick Ainsworth, Sönke Detlefsen, Michael Bau Mortensen, Per Pfeiffer, Line Schmidt Tarpgaard, Martin Graversen	8
12	First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study 2022 ·British Journal of Cancer ·Eric Van Cutsem, Iwona Danielewicz, Mark Saunders, Per Pfeiffer, Guillem Argilés, Christophe Borg, Rob Glynne‐Jones, Cornelis J.A. Punt, Agnès J. van de Wouw, М. Yu. Fedyanin, Daniil Stroyakovskiy, Hendrik Kroening, Pilar García‐Alfonso, Harpreet Wasan, Alfredo Falcone, Ronan Fougeray, Anton Egorov, Nadia Amellal, Vladimir Moiseyenko	9
13	Patterns of Palliative Chemotherapy and Survival in Patients With Pancreatic Cancer Focusing on Age 2021 ·Pancreas ·(unknown), Claus Wilki Fristrup, Benny Vittrup Jensen, Per Pfeiffer, Britta Weber, Mette Yilmaz, Laurids Østergaard Poulsen, Morten Ladekarl, Kell Østerlind, Jim S. Larsen, Halla Skúladóttir, Martin Bøgsted, Sture Falkmer	3
14	Initial treatment and survival in 4163 Danish patients with pancreatic cancer: A nationwide unselected real-world register study 2020 ·European Journal of Cancer ·(unknown), Claus Wilki Fristrup, Benny Vittrup Jensen, Per Pfeiffer, Britta Weber, Mette Yilmaz, Laurids Østergaard Poulsen, Morten Ladekarl, Kell Østerlind, Jim S. Larsen, Halla Skúladóttir, Carsten Palnæs Hansen, Michael Bau Mortensen, Frank Viborg Mortensen, Mogens Sall, Sönke Detlefsen, Martin Bøgsted, Sture Falkmer	15
15	Mutational profiling and immunohistochemical analysis of a surgical series of ampullary carcinomas 2019 ·Journal of Clinical Pathology ·(unknown), (unknown), Per Pfeiffer, Michael Bau Mortensen, Claus Wilki Fristrup, Sönke Detlefsen	13
16	Early changes in tests of peripheral nerve function during oxaliplatin treatment and their correlation with chemotherapy‐induced polyneuropathy symptoms and signs 2019 ·European Journal of Neurology ·Thomas Krøigård, (unknown), Martin Wirenfeldt, Henrik Daa Schrøder, Camilla Qvortrup, Per Pfeiffer, David Gaist, Søren H. Sindrup	19
17	Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic Cancer 2019 ·Cancer Epidemiology Biomarkers & Prevention ·Inna M. Chen, Astrid Z. Johansen, Christian Dehlendorff, Benny Vittrup Jensen, Stig E. Bojesen, Per Pfeiffer, Jon Kroll Bjerregaard, Svend Erik Nielsen, (unknown), Niels Henrik Holländer, Mette Yilmaz, (unknown), Julia S. Johansen	12
18	Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx ^® ): a placebo-controlled randomised phase II study (PLIANT) 2017 ·Acta Oncologica ·Bengt Glimelius, Nebojša Manojlović, Per Pfeiffer, Baadur Mosidze, G. Kurteva, (unknown), Devalingam Mahalingam, Peter Buhl Jensen, Jan Kowalski, (unknown), (unknown), (unknown)	63
19	Characterization and diagnostic evaluation of chronic polyneuropathies induced by oxaliplatin and docetaxel comparing skin biopsy to quantitative sensory testing and nerve conduction studies 2014 ·European Journal of Neurology ·Thomas Krøigård, Henrik Daa Schrøder, Camilla Qvortrup, Lise Eckhoff, Per Pfeiffer, David Gaist, Søren H. Sindrup	72
20	Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC) 2008 ·Acta Oncologica ·Lene Weber Vestermark, (unknown), Camilla Qvortrup, Flemming Hansen, Claus Bisgaard, Gunnar Baatrup, P. Rasmussen, Per Pfeiffer	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact